Lexaria signs manufacturing and license agreements with BevNology

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, is pleased to announce the signing of two agreements with Atlanta-based BevNology LLC.

The first agreement is a manufacturing operating agreement that expands production capabilities for Lexaria’s own growing list of business-to-business clientele interested in purchasing DehydraTECH-powered active ingredients for consumer packaged-goods brands. A new processing facility custom-built by BevNology is operational that increases and broadens production capacity and is currently serving Lexaria’s corporate clients. Lexaria has moved and installed all required commercial DehydraTECH manufacturing equipment into BevNology’s new facility as it prepares for future growth in its B2B ingredient processing business.

The second agreement is a commercial license agreement that empowers BevNology to offer DehydraTECH products with active ingredients derived from hemp, including cannabidiol (“CBD”), under BevNology and partnered brands. For powdered DehydraTECH formulations, this agreement is non-exclusive. For liquid DehydraTECH formulations, where BevNology has highly specialized skills and capabilities, the license is non-exclusive in most areas of the world but includes limited exclusivity rights in the United States only, that require certain minimum fee payments in order to maintain those rights. Lexaria will receive royalties from BevNology as a result of their utilization of this license. The only countries specifically excluded under this license are Japan, the Republic of Korea, and the People’s Republic of China.

“We are very excited about this expanded partnership with Lexaria, which will further strengthen our longtime relationship as well as boost our development and manufacturing capabilities through the addition of our new facility. This will allow us to expand our product and service offerings,” said Gonzalo de Aristegui, partner and co-founder of Bevnology.

Founded 10 years ago by Louis Heinsz and Gonzalo de Aristegui, Bevnology is the product development and manufacturing arm of IBC (InterContinental Beverage Capital). It operates a lab and manufacturing facility outside Atlanta, Georgia.

“These agreements build on a long-standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology,” said Chris Bunka, CEO of Lexaria.  “BevNology’s formulation and production capabilities are class leading, and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.”

Bevnology has advanced capabilities that support best-in-class beverage formulations and, together with Lexaria’s superior technology, could make industry-leading beverage products a reality for many brands. Lexaria’s DehydraTECH TM -CBD nano emulsification formulation and processing techniques exhibited exceptional stability one year after production with less than 1% variability in CBD potency in fractions sampled from the top, middle, and bottom of the beverage formulation without physical mixing or agitation; and, CBD content was verified at 93.4% of target potency and also evidenced excellent microbial purity after 12 months.

The latest stability testing occurred 25 months after originally bottling, with slightly higher variability but still retaining an average of 78% of originally formulated CBD. As well, the microbiologic purity and cleanliness of the product exceeded all requirements 25 months after bottling.

Lexaria’s DehydraTECH technology has been embraced by several consumer-packaged goods brands currently available in over 7,000 stores in the US and Japan, as well as through direct-to-consumer online retail portals.

For more information:
Lexaria Bioscience
info@lexariabioscience.com  
www.lexariabioscience.com  


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber